- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | HeartSciences Inc.: HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining | 2 | GlobeNewswire (USA) | ||
| 06.10. | HeartSciences Inc.: HeartSciences Receives FDA 510(k) Clearance for its MyoVista wavECGTM Device | 160 | GlobeNewswire (Europe) | Southlake, TX, Oct. 06, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing... ► Artikel lesen | |
| 02.10. | HeartSciences Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.09. | HeartSciences Inc. - 8-K, Current Report | 7 | SEC Filings | ||
| 15.09. | Heart Test Laboratories GAAP EPS of -$0.86 misses by $0.11 | 8 | Seeking Alpha | ||
| 15.09. | HeartSciences Inc.: HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update | 262 | GlobeNewswire (Europe) | Proposed business combination with Fortitude, a vertically-integrated digital asset mining platform anchored in Zcash, continues to progress, with closing expected in Q4 calendar 2026 Commercial effort... ► Artikel lesen | |
| HEARTSCIENCES Aktie jetzt für 0€ handeln | |||||
| 14.09. | HeartSciences Inc. - 10-Q, Quarterly Report | 7 | SEC Filings | ||
| 25.08. | HeartSciences Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 19.08. | HeartSciences Inc.: Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration | 348 | GlobeNewswire (Europe) | Fortitude purchased approximately $1,000,000 of HeartSciences' shares of common stock at $2.43 per share, a 22% premium to the closing price on the purchase dateThe exchange ratio under the merger... ► Artikel lesen | |
| 18.08. | HeartSciences Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.08. | HeartSciences Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 29.07. | HeartSciences Inc.: HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results | 298 | GlobeNewswire (Europe) | Company believes proposed Fortitude Mining Holdings business combination represents a significant value creation opportunity for the Company's shareholders Fiscal 2026 saw the full commercial launch... ► Artikel lesen | |
| 23.07. | HeartSciences Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.07. | HeartSciences Inc.: HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K | 1 | GlobeNewswire (USA) | ||
| 23.07. | HeartSciences Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 10.07. | HeartSciences Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.06. | Fortitude And HeartSciences Announce Business Combination | 1 | pulse2.com | ||
| 23.06. | HeartSciences Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.06. | Fortitude Mining to merge with HeartSciences in all-stock deal | 2 | Investing.com | ||
| 23.06. | Fortitude Mining Holdings, Inc. and HeartSciences Inc. Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets | 366 | Business Wire | FAIRPORT, N.Y.--(BUSINESS WIRE)--Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, and HeartSciences Inc. (Nasdaq: HSCS) ("HeartSciences")... ► Artikel lesen |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,602 | -0,04 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Legal Officer Transition | NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,072 | -2,69 % | PAUKENSCHLAG: Könnte die Aktie von Sernova Biotherapeutics nach 12,7 % Plus jetzt komplett durchstarten? - Das dürfen Sie nicht verpassen! | ||
| CERENOME | 1,410 | +1,15 % | Cerenome, Inc.: Cerenome Announces New Dual Mechanism of Action Featuring Lethal DNA Damage and Beneficial Immunomodulation Supporting Lead Investigational Drug REYOBIQ' | ||
| ATOSSA THERAPEUTICS | 2,280 | +0,88 % | Atossa Therapeutics: Stammaktien handeln ab sofort gekoppelt mit Contingent Value Rights | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 14,400 | 0,00 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,625 | -2,65 % | Joint Venture von Co-Diagnostics zu saudi-arabischem Fertigungsforum eingeladen | ||
| QUIDELORTHO | 12,585 | +0,36 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,300 | 0,00 % | Oppenheimer reiterates Veru stock rating ahead of obesity trial data | ||
| LIFEWARD | 5,490 | 0,00 % | 6,4 Millionen US-Dollar pro Patient: Warum Medtronic, Lifeward und NurExone an drei Stufen der Rückenmarksversorgung ansetzen | ||
| CLOVER HEALTH INVESTMENTS | 4,220 | -0,71 % | Clover Health Investments, Corp.: Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States | ||
| SENSEONICS | 7,250 | +2,11 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| NANO-X IMAGING | 0,377 | -2,00 % | Nanox meldet vorläufigen Q3-Umsatz von bis zu $4,4 Millionen | ||
| TEMPEST THERAPEUTICS | 0,527 | +0,57 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| IMUNON | 1,030 | 0,00 % | IMUNON veräußert ThermoDox-Rechte an VoxelDox Therapeutics |
Das Unternehmen HEARTSCIENCES INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +3,37 % bei einem Aktienkurs von 3,680 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HEARTSCIENCES INC finden Sie auf Wallstreet Online.